2021
DOI: 10.1053/j.gastro.2021.06.078
|View full text |Cite
|
Sign up to set email alerts
|

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
177
0
16

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 234 publications
(194 citation statements)
references
References 93 publications
(102 reference statements)
1
177
0
16
Order By: Relevance
“…In addition, an increased risk of gastric cancer is noted among individuals with incomplete (colonic, type III) and/or widespread intestinal metaplasia of the mucous membrane [50,51]. The modified OLGIM system (Operative Link on Gastric Intestinal Metaplasia Assessment), being more reproducible, offers only an assessment of the intestinal metaplasia presence as the main indicator of chronic gastritis stage [52,53]. Although the question of comparing these classifications from the sensitivity point remains controversial, since the use of OLGIM, which is more reproducible in practical application, may underestimate the true severity of absolute (non-metaplastic) atrophy [54][55][56].…”
Section: Morphological Examinationmentioning
confidence: 99%
“…In addition, an increased risk of gastric cancer is noted among individuals with incomplete (colonic, type III) and/or widespread intestinal metaplasia of the mucous membrane [50,51]. The modified OLGIM system (Operative Link on Gastric Intestinal Metaplasia Assessment), being more reproducible, offers only an assessment of the intestinal metaplasia presence as the main indicator of chronic gastritis stage [52,53]. Although the question of comparing these classifications from the sensitivity point remains controversial, since the use of OLGIM, which is more reproducible in practical application, may underestimate the true severity of absolute (non-metaplastic) atrophy [54][55][56].…”
Section: Morphological Examinationmentioning
confidence: 99%
“…Moreover, the incidence of open-type atrophic gastritis was significantly higher in the anti-H. pylori-Ab positive group and had a strong correlation to the incompetent pylorus group. Atrophic gastritis is the first step in Correa's cascade [36]. Pathologically, original gastric glands are replaced by intestinal metaplasia and pseudopyloric metaplasia, with or without fibrosis [37].…”
Section: Discussionmentioning
confidence: 99%
“…It is estimated that 0.1% to 0.3% of atrophic gastritis cases develop into gastric adenocarcinomas annually [36]. Patients diagnosed with open-type endoscopic atrophy have a higher risk of gastric cancer development than those diagnosed with closed-type [39][40][41].…”
Section: Discussionmentioning
confidence: 99%
“…Das hellblaue Kamm-Zeichen (Light blue Crest) definiert als feine, blau-weiße Linien auf den Kämmen der Epitheloberfläche, ist charakteristisch für die IM, mit einer Sensitivität und Spezifität von ca. 90 % [12,13]. Die sogenannten weißen undurchsichtigen Felder (White opaque Substance) resultieren aus Ansammlungen mikroskopisch kleiner Lipidtröpfchen und stellen ebenfalls einen nützlichen Marker für das Vorliegen einer IM, mit hoher Spezifität und begrenzter Sensitivität.…”
Section: äTiologieunclassified